Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Specific Antigens”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00035217
What this trial is testing

Follow-Up Study for Men Diagnosed With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening Program

Who this might be right for
Prostate Cancer
National Center for Research Resources (NCRR)
Not applicableNot Yet RecruitingNCT07644754
What this trial is testing

Patients With Metastasized Prostate Cancer Whose Prostate-specific Antigen-level (PSA) Remains >0,2 ng/ml After Six Months of Dual Antihormonal Therapy Will Receive Radiotherapy to the Prostate and Radiotherapy to Refractory Metastases

Who this might be right for
Prostate CancerProstate Cancer Metastatic DiseaseProstate Cancer Metastatic to Bone
University Hospital Tuebingen 27
Not applicableEnded earlyNCT04745871
What this trial is testing

Diagnostic Performance of PSMA PET/CT for Pre-operative Lymph Node Assessment in Intermediate and High-risk Non-metastasic Prostate Cancer (PREOP-PSMA ).

Who this might be right for
Prostate Cancer
University Hospital, Brest 112
Testing effectiveness (Phase 2)Study completedNCT00678054
What this trial is testing

Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for Patients With Rising Prostate-Specific Antigen (PSA)

Who this might be right for
Prostate Cancer
University of California, San Francisco 30
Testing effectiveness (Phase 2)Looking for participantsNCT05761366
What this trial is testing

Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor

Who this might be right for
Malignancy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 400
Not applicableUnknownNCT04393376
What this trial is testing

PSA Glycomics Assay for Early Detection of Prostate Cancer

Who this might be right for
Prostate CancerPSA
Prof.dr. H.P. Beerlage 150
Not applicableNot Yet RecruitingNCT07733440
What this trial is testing

PROstate Cancer Risk Calculator for ACTionable Clinical Decision-making in Nigeria

Who this might be right for
Prostate CancerRisk AssessmentClinical Decision Support Systems+12 more
Ahmadu Bello University 89
Testing effectiveness (Phase 2)Looking for participantsNCT07523529
What this trial is testing

Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors

Who this might be right for
Advanced UnresectableMetastatic
Beijing Biotech 72
Not applicableActive Not RecruitingNCT04024475
What this trial is testing

Prostate Cancer Biobank

Who this might be right for
Prostatic Neoplasms
Swiss Cancer Institute 1,323
Early research (Phase 1)Looking for participantsNCT05354375
What this trial is testing

Clinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant Prostate Cancer

Who this might be right for
Immunotherapy
The Affiliated Hospital of Xuzhou Medical University 20
Not applicableStudy completedNCT03881709
What this trial is testing

The Efficacy of Decision Support E-book for Prostate Biopsy Decision Making

Who this might be right for
Prostate-Specific Antigen
National Taipei University of Nursing and Health Sciences 110
Not applicableStudy completedNCT07477756
What this trial is testing

A Real-world Study of Characteristics, Treatment Patterns, and Clinical Outcomes Among Lutetium-177 Vipivotide Tetraxetan Treated Patients

Who this might be right for
Prostate Cancer
Novartis Pharmaceuticals 1,247
Testing effectiveness (Phase 2)Study completedNCT00596895
What this trial is testing

Isoflavone in Prostate-specific Antigen Recurrent Prostate Cancer

Who this might be right for
Biochemical Recurrent Prostate Cancer
University of Florida 20
Testing effectiveness (Phase 2)Looking for participantsNCT07190300
What this trial is testing

TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Novartis Pharmaceuticals 181
Not applicableUnknownNCT05009186
What this trial is testing

Changing of Prostate Specific Antigen Value in Patients With Covid-19

Who this might be right for
Covid19Prostate Specific Antigen
Saglik Bilimleri Universitesi 100
Testing effectiveness (Phase 2)Study completedNCT00676780
What this trial is testing

Green Tea Extract and Prostate Cancer

Who this might be right for
Prostate Cancer
Louisiana State University Health Sciences Center Shreveport 33
Testing effectiveness (Phase 2)Looking for participantsNCT07259213
What this trial is testing

Terbium 161 (161Tb)-RAD402 in Participants With CRPC

Who this might be right for
Castration-resistant Prostate Cancer
Radiopharm Theranostics, Ltd 73
Early research (Phase 1)Study completedNCT00178113
What this trial is testing

A Pilot Study of Lycopene Supplementation in Prostatic Intraepithelial Neoplasia

Who this might be right for
Prostatic Intraepithelial Neoplasia
University of Pittsburgh 80
Not applicableUnknownNCT03632980
What this trial is testing

Dynamic Focusing Evaluation for Prostate Cancer Treatment

Who this might be right for
Cancer of Prostate
EDAP TMS S.A. 180
Large-scale testing (Phase 3)Study completedNCT00304759
What this trial is testing

PROFIT - Prostate Fractionated Irradiation Trial

Who this might be right for
Prostate Cancer
Ontario Clinical Oncology Group (OCOG) 1,204
Next Page